1. Home
  2. RUM vs PTGX Comparison

RUM vs PTGX Comparison

Compare RUM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rumble Inc.

RUM

Rumble Inc.

HOLD

Current Price

$9.47

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$150.25

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUM
PTGX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
9.5B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RUM
PTGX
Price
$9.47
$150.25
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$108.23
AVG Volume (30 Days)
4.1M
451.6K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
80.72
N/A
EPS
N/A
2.35
Revenue
$100,622,320.00
N/A
Revenue This Year
$209.98
$874.25
Revenue Next Year
$40.99
N/A
P/E Ratio
N/A
$63.62
Revenue Growth
5.38
N/A
52 Week Low
$4.62
$57.45
52 Week High
$10.60
$160.81

Technical Indicators

Market Signals
Indicator
RUM
PTGX
Relative Strength Index (RSI) 70.60 56.62
Support Level $5.37 $94.48
Resistance Level $10.54 $160.81
Average True Range (ATR) 0.75 5.41
MACD 0.24 -0.95
Stochastic Oscillator 76.92 24.89

Price Performance

Historical Comparison
RUM
PTGX

About RUM Rumble Inc.

RUM Group Inc focused is to maximize the power of human imagination through an independent technology ecosystem built on privacy, resilience, and an open alternative to Big Tech. Rumble gives human creativity a voice, a video and media platform built for creators and audiences who value free expression. Quake AI is a cloud and AI-infrastructure business, delivering the compute, data-center capacity, and blockchain infrastructure for the agentic era.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: